Drug profile · INN
pentosan polysulfate sodium
ELMIRON
pentosan polysulfate sodium (ELMIRON) is a unknown. Route of administration: oral. Current US regulatory status: approved.
FDA: approved EMA: approved Genito-urinary system and sex hormones (G04) G04BX15
US status approved
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — pentosan polysulfate sodium
- US status
- approved
- Class
- Genito-urinary system and sex hormones (G04)
- Route
- ORAL
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
pentosan polysulfate sodium (ELMIRON) is a unknown. Route of administration: oral. Current US regulatory status: approved.
Key facts
INN pentosan polysulfate sodium
Brand ELMIRON
Mechanism Unknown
Therapeutic class Genito-urinary system and sex hormones (G04)
Route ORAL
Formulation CAPSULE
ATC code G04BX15
Mechanism of action
Unknown
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
| EMA | approved | — |
Related & competitor drugs
Frequently asked questions
What is pentosan polysulfate sodium?
pentosan polysulfate sodium (ELMIRON) is a unknown. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for pentosan polysulfate sodium?
ELMIRON is a marketed brand name for pentosan polysulfate sodium. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of pentosan polysulfate sodium?
pentosan polysulfate sodium has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.